THC Therapeutics, Inc. financial data

Location
Las Vegas, NV
Fiscal year end
31 July
Latest financial report
10-Q - Q1 2024 - 13 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.04% % -93%
Debt-to-equity -98% % 1.8%
Return On Assets -4389% % -177860%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40,226,149 shares
Common Stock, Shares, Outstanding 38,866,149 shares 14%
Common Stock, Value, Issued $40,266 USD 23%
Weighted Average Number of Shares Outstanding, Basic 38,334,816 shares 17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Cost of Revenue $0 USD
General and Administrative Expense $19,333 USD 171%
Operating Income (Loss) $574,718 USD 41%
Net Income (Loss) Attributable to Parent $562,779 USD -30337%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $849 USD -14%
Assets $11,813 USD -11%
Liabilities, Current $3,431,644 USD 7.6%
Liabilities $3,431,644 USD 7.6%
Retained Earnings (Accumulated Deficit) $38,953,783 USD -1.5%
Stockholders' Equity Attributable to Parent $3,519,831 USD -7.4%
Liabilities and Equity $11,813 USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 40,266,149 shares 18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $849 USD 5560%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 6,747,500 shares -33%
Additional Paid in Capital $41,906,132 USD 1.6%
Preferred Stock, Shares Outstanding 0 shares -100%
Interest Expense $77,552 USD 64%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%